Clinical Evaluation of the TRVD™ System in ADHF

NATerminatedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

August 7, 2015

Primary Completion Date

April 30, 2019

Study Completion Date

May 31, 2019

Conditions
Acute Heart FailureCongestive Heart FailureHeart Failure, Congestive
Interventions
DEVICE

TRVD Therapy

A catheter-mounted expandable flow pump is to be deployed in a transfemoral venous catheterization procedure. Once in place, renal venous pressure is reduced to a pre-selected physiologic target pressure and kept there for up to 24 hours. After termination of TRVD therapy, the device is removed.

Trial Locations (3)

9300

OLV-Hospital Aalst, Belgium, Aalst

10000

Clinical Hospital Centre Zagreb, Zagreb

Unknown

Zemun Clinical Hospital Center, Belgrade

Sponsors
All Listed Sponsors
lead

Magenta Medical Ltd.

INDUSTRY

NCT03621436 - Clinical Evaluation of the TRVD™ System in ADHF | Biotech Hunter | Biotech Hunter